Identification of oxidative degradates of the TRIS salt of a 5,6,7,8-tetrahydro-1,8-naphthyridine derivative by LC/MS/MS and NMR spectroscopy-interactions between the active pharmaceutical ingredient and its counterion

By Wu Y.   Hwang T.-L.   Algayer K.   Xu W.   Wang H.   Procopio A.   DeBusi L.   Yang C.-Y.   Matuszewska B.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Iss. 5, 2003-12 ,pp. : 999-1015

Elsevier

Access to resources Recommend Favorite

Interactions between bendroflumethiazide and water-soluble polymers. III. Chemical degradation

By Frontini R.   Mielck J.B.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 44, Iss. 1, 1997-07 ,pp. : 85-88

Elsevier

Access to resources Recommend Favorite

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection

By Chollet John L.   Jozwiakowski Michael J.  

Drug Development and Industrial Pharmacy, Vol. 38, Iss. 5, 2012-05 ,pp. : 540-549

Informa Healthcare

Access to resources Recommend Favorite

Formulation of tablets containing an ‘in-process’ amorphized active pharmaceutical ingredient

By Jójárt-Laczkovich Orsolya   Szabó-Révész Piroska  

Drug Development and Industrial Pharmacy, Vol. 37, Iss. 11, 2011-11 ,pp. : 1272-1281

Informa Healthcare

Access to resources Recommend Favorite

Early Prediction of Pharmaceutical Oxidation Pathways by Computational Chemistry and Forced Degradation

By Reid Darren L.   Calvitt C. Jeffrey   Zell Mark T.   Miller Kenneth G.   Kingsmill Carol A.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1708-1717

Springer Publishing Company

Access to resources Recommend Favorite